Skip to main
RDNT

RadNet (RDNT) Stock Forecast & Price Target

RadNet (RDNT) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 80%
Buy 20%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

RadNet Inc. is expected to benefit from ongoing technology investments that will enhance productivity and automation, which is particularly crucial in a challenging labor environment. The company's joint venture (JV) strategy is anticipated to support continued volume growth, improved market penetration, and increased contracting leverage, positioning RadNet favorably in the competitive diagnostic imaging market. Furthermore, robust demand trends, coupled with persistent patient backlogs, are driving strong growth in advanced procedure categories, contributing to significant margin benefits and overall positive financial performance.

Bears say

RadNet faces several significant risks that contribute to a negative outlook on its stock, including potential reimbursement pressures and changes that could adversely affect its revenue streams. Additionally, the company is grappling with labor challenges, which could hinder operational efficiency and profitability. Furthermore, the ability of RadNet's Digital Health segment to achieve profitability remains in question, particularly in light of ongoing deployment efforts such as the TechLive rollout which has seen mixed results despite some initial success.

RadNet (RDNT) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 80% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of RadNet and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About RadNet (RDNT) Forecast

Analysts have given RadNet (RDNT) a Strong Buy based on their latest research and market trends.

According to 5 analysts, RadNet (RDNT) has a Strong Buy consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

RadNet (RDNT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.